Brief: New Ray Medicine International Says Acquisition Of 16% Of Of Target Company
16/05/2024 18:46
May 16 (Reuters) - New Ray Medicine International
Holding Ltd 6108.HK :
* ACQUISITION OF 16% OF ISSUED SHARE CAPITAL OF TARGET
COMPANY
* DEAL FOR HK$17.3 MILLION
* UNIT AGREED TO SELL 16 SHARES OF CHINA NVWA PHARMACEUTICAL
GROUP
Further company coverage: 6108.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on New Ray Medicine International Holding
See all newsBrief: New Ray Medicine International Holding Says Chu Xueping Resigns As Executive Director
Brief: New Ray Medicine International Posts FY Net Loss Attributable HK$20.1 Million
Brief: New Ray Medicine International To Place Up To 33.4 Million Shares
Brief: New Ray Medicine International Says China New Rich Enters Cooperation Agreement
Brief: New Ray Medicine International Says Unit Disposes 801,000 Jiangxi Rimag Shares For HK$12.8 Million